These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10736983)

  • 41. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study.
    Fukuchi T; Kanemoto K
    Int Clin Psychopharmacol; 2002 Mar; 17(2):53-8. PubMed ID: 11890186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute cholestasis by fluoxetine.
    Cosme A; Barrio J; Lobo C; Gil I; Castiella A; Arenas JI
    Am J Gastroenterol; 1996 Nov; 91(11):2449-50. PubMed ID: 8931446
    [No Abstract]   [Full Text] [Related]  

  • 43. Personality disorder scores improve with effective pharmacotherapy of depression.
    Black KJ; Sheline YI
    J Affect Disord; 1997 Mar; 43(1):11-8. PubMed ID: 9127826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.
    Walkup J; Labellarte M; Riddle MA; Pine DS; Greenhill L; Fairbanks J; Klein R; Davies M; Sweeney M; Abikoff H; Hack S; Klee B; Bergman RL; Lynn D; McCracken J; March J; Gammon P; Vitiello B; Ritz L; Roper M;
    J Child Adolesc Psychopharmacol; 2002; 12(3):175-88. PubMed ID: 12427292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoglycemia associated with the use of fluoxetine.
    Deeg MA; Lipkin EW
    West J Med; 1996 Mar; 164(3):262-3. PubMed ID: 8775944
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluvoxamine treatment of trichotillomania.
    Stanley MA; Breckenridge JK; Swann AC; Freeman EB; Reich L
    J Clin Psychopharmacol; 1997 Aug; 17(4):278-83. PubMed ID: 9241007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
    Vandel S; Bertschy G; Baumann P; Bouquet S; Bonin B; Francois T; Sechter D; Bizouard P
    Pharmacol Res; 1995 Jun; 31(6):347-53. PubMed ID: 8685072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum beta-endorphin level in patients with depression on fluvoxamine.
    Djurović D; Milić-Askrabić J; Majkić-Singh N
    Farmaco; 1999 Mar; 54(3):130-3. PubMed ID: 10371024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients.
    Strik JJ; Honig A; Lousberg R; Cheriex EC; Van Praag HM
    Int Clin Psychopharmacol; 1998 Nov; 13(6):263-7. PubMed ID: 9861576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
    Lesaffre E; Molenberghs G; Dewulf L
    Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.
    Miyaoka T; Yasukawa R; Mihara T; Shimizu Y; Tsubouchi K; Maeda T; Mizuno S; Uegaki J; Inagaki T; Horiguchi J; Tachibana H
    J ECT; 2003 Sep; 19(3):170-2. PubMed ID: 12972988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
    Kohn Y; Weizman A; Apter A
    Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An interaction between carbamazepine and fluvoxamine.
    Martinelli V; Bocchetta A; Palmas AM; Del Zompo M
    Br J Clin Pharmacol; 1993 Dec; 36(6):615-6. PubMed ID: 12959283
    [No Abstract]   [Full Text] [Related]  

  • 54. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinicopsychological and therapeutic significance in the depression-pain relationship].
    Chiriţa V; Chiriţa R; Cosmovici N; Mungiu OC; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(2):257-60. PubMed ID: 7997667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effects and tolerability of fluvoxamine treatment in adolescents with dysthymia.
    Rabe-Jablonska J
    J Child Adolesc Psychopharmacol; 2000; 10(1):9-18. PubMed ID: 10755577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of adolescent body dysmorphic disorder treated with fluvoxamine.
    Khan S; Decker D
    J Child Adolesc Psychopharmacol; 2001; 11(1):105-7. PubMed ID: 11322739
    [No Abstract]   [Full Text] [Related]  

  • 58. Antidepressant response and fluvoxamine plasma concentrations: a pilot study.
    Schwarzenbach F; Netillard C; Demoly P; Bisschop D; Limat S; Bouquet S; Vandel S; Bel AM; Woronoff-Lemsi MC
    Pharm World Sci; 2003 Feb; 25(1):27-9. PubMed ID: 12661474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine.
    Duan DM; Tu Y; Chen LP; Wu ZJ
    J Tradit Chin Med; 2009 Sep; 29(3):167-73. PubMed ID: 19894377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project.
    Passik SD; Kirsh KL; Theobald D; Donaghy K; Holtsclaw E; Edgerton S; Dugan W
    J Pain Symptom Manage; 2002 Sep; 24(3):318-27. PubMed ID: 12458113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.